Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

33.65
-0.3282-0.97%
Post-market: 33.51-0.1404-0.42%16:10 EDT
Volume:3K
Turnover:102.82K
Market Cap:13.46M
PE:- -
High:33.77
Open:33.77
Low:33.14
Close:33.98
52wk High:34.98
52wk Low:27.25
Shares:400.00K
Float Shares:400.00K
Volume Ratio:1.96
T/O Rate:0.77%
Dividend:0.08
Dividend Rate:0.24%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Vir Biotechnology Names Aziz Sawaf as CFO Effective Oct. 5, 2026

Reuters
·
Oct 01

Jefferies Adjusts Price Target on Merck & Co to $177 From $175, Keeps Buy Rating

MT Newswires Live
·
Oct 01

Coty Names Kara Langan General Manager, U.S. Consumer Beauty Division

Reuters
·
Oct 01

Merck Schedules Third-Quarter Sales and Earnings Conference Call with Investors and Analysts

Reuters
·
Oct 01

Johnson & Johnson (JNJ) Stock Could Be Undervalued On Future Cash Flow

Simply Wall St.
·
Oct 01

Merck & Co Inc : Jefferies Raises Target Price to $177 from $175

THOMSON REUTERS
·
Oct 01

RBC Capital Keeps Their Hold Rating on Merck & Company (MRK)

TIPRANKS
·
Oct 01

Nexsen reshapes leadership to drive growth in point-of-care diagnostics

TIPRANKS
·
Oct 01

Estee Lauder Cos. Cl a Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Oct 01

Edwards Lifesciences Corp. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Oct 01

Grindr to acquire Freddie for $250M in cash and stock

TIPRANKS
·
Oct 01

Abbott Laboratories Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Oct 01

Gilead Sciences Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Oct 01

Moderna Inc. Stock Sheds 5.4%, Underperforms Peers

Dow Jones
·
Oct 01

Merck, 3M Share Losses Contribute to Dow's 286-Point Drop

Dow Jones
·
Oct 01

Gilead put volume heavy and directionally bearish

TIPRANKS
·
Oct 01

Dow Drops 150 Points on Losses for Shares of Sherwin-Williams Co., Merck

Dow Jones
·
Oct 01

Lilly's Closely Watched Obesity Combination Therapy Shows Greater Weight Loss in Mid-Stage Trial

Deep News
·
Oct 01

Verici Dx boosts Tutivia growth and expands transplant diagnostics footprint

TIPRANKS
·
Oct 01

Edwards Lifesciences' TAVR Evaluation in Moderate Aortic Stenosis Among Most Awaited Clinical Trial Readouts, Oppenheimer Says

MT Newswires Live
·
Sep 30